220 related articles for article (PubMed ID: 22438253)
21. Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking.
Mayol K; Biajoux V; Marvel J; Balabanian K; Walzer T
Blood; 2011 Nov; 118(18):4863-71. PubMed ID: 21911833
[TBL] [Abstract][Full Text] [Related]
22. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor.
Honczarenko M; Le Y; Glodek AM; Majka M; Campbell JJ; Ratajczak MZ; Silberstein LE
Blood; 2002 Oct; 100(7):2321-9. PubMed ID: 12239139
[TBL] [Abstract][Full Text] [Related]
23. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
[TBL] [Abstract][Full Text] [Related]
24. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
[TBL] [Abstract][Full Text] [Related]
25. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.
Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH
J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686
[TBL] [Abstract][Full Text] [Related]
26. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.
Walters KB; Green JM; Surfus JC; Yoo SK; Huttenlocher A
Blood; 2010 Oct; 116(15):2803-11. PubMed ID: 20592249
[TBL] [Abstract][Full Text] [Related]
27. [WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].
Bock I; Dugué F; Loppinet E; Bellanné-Chantelot C; Bénet B
Ann Biol Clin (Paris); 2014; 72(1):111-9. PubMed ID: 24492099
[TBL] [Abstract][Full Text] [Related]
28. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients.
Boujedidi H; Robert O; Bignon A; Cassard-Doulcier AM; Renoud ML; Gary-Gouy H; Hemon P; Tharinger H; Prévot S; Bachelerie F; Naveau S; Emilie D; Balabanian K; Perlemuter G
Clin Sci (Lond); 2015 Feb; 128(4):257-67. PubMed ID: 25074471
[TBL] [Abstract][Full Text] [Related]
30. Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.
Mc Guire PJ; Cunningham-Rundles C; Ochs H; Diaz GA
Clin Immunol; 2010 Jun; 135(3):412-21. PubMed ID: 20226738
[TBL] [Abstract][Full Text] [Related]
31. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
32. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
Hernandez PA; Gorlin RJ; Lukens JN; Taniuchi S; Bohinjec J; Francois F; Klotman ME; Diaz GA
Nat Genet; 2003 May; 34(1):70-4. PubMed ID: 12692554
[TBL] [Abstract][Full Text] [Related]
34. [CXCR4 as a rheostat of humoral response].
Khamyath M; Bonaud A; Balabanian K; Espéli M
Med Sci (Paris); 2023 Jan; 39(1):23-30. PubMed ID: 36692314
[TBL] [Abstract][Full Text] [Related]
35. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
36. Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome.
Kumar R; Milanesi S; Szpakowska M; Dotta L; Di Silvestre D; Trotta AM; Bello AM; Giacomelli M; Benedito M; Azevedo J; Pereira A; Cortesao E; Vacchini A; Castagna A; Pinelli M; Moratto D; Bonecchi R; Locati M; Scala S; Chevigné A; Borroni EM; Badolato R
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36883568
[TBL] [Abstract][Full Text] [Related]
37. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
Aboumrad E; Madec AM; Thivolet C
Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
[TBL] [Abstract][Full Text] [Related]
39. Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
Merati N; Sivachandran S; Jfri A; Ben-Shoshan M; Vinh DC; Popradi G; Litvinov IV
Skin Therapy Lett; 2022 Mar; 27(2):1-5. PubMed ID: 35385630
[TBL] [Abstract][Full Text] [Related]
40. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.
Sawada S; Gowrishankar K; Kitamura R; Suzuki M; Suzuki G; Tahara S; Koito A
J Exp Med; 1998 May; 187(9):1439-49. PubMed ID: 9565636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]